On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...